Showing results (1571-1580 of 8,901) with videos related to
Sort By:
Pageof 891
Schizophrenia Research|October 7, 2023
Risk stratification for treating people at ultra-high risk for psychosis: A cost-effectiveness analysisOlajumoke M Ologundudu, Lena Palaniyappan, Lauren E Cipriano, et al.Schizophrenia Research|October 3, 2023
A systematic review and meta-analysis of the effect of clozapine on cognitive functions in patients with treatment-resistant schizophreniaNatalie Kwok Wing Cheuk, Wing Tse, Harry Kam Hung Tsui, et al.Schizophrenia Research|October 2, 2023
Inflammation and cognitive performance in first-episode schizophrenia spectrum disorders: The moderating effects of childhood traumaBarbora Keřková, Karolína Knížková, Monika Večeřová, et al.Schizophrenia Research|September 29, 2023
A Chinese medicine called Danggui Longhui may be a new clinically relevant clozapine inducer: Two case reports identified by therapeutic drug monitoringFei Jia, Yan-Nan Zang, Can-Jun Ruan, et al.Schizophrenia Research|September 28, 2023
Prevalence and predictors of QTc prolongation in patients seen in a clozapine clinic in a real-world setting in AustraliaAnoop Sankaranarayanan, Sharmin Kazi, Chittaranjan AndradeSchizophrenia Research|October 1, 2023
COPSYC-19: The impact of early phase lockdown on mental health among people with psychotic disordersAndreas Seierstad, Olivia Schjøtt-Pedersen, Stig Evensen, et al.Schizophrenia Research|September 16, 2023
Effectiveness of acceptance and commitment therapy for inpatients with psychosis: Implementation feasibility and acceptability from a pilot randomized controlled trialBrandon A Gaudiano, Stacy Ellenberg, Jennifer E Johnson, et al.Schizophrenia Research|September 18, 2023
Effect of early electroconvulsive therapy on length of stay in patients with bipolar, depressive and psychotic disordersShih Ee Goh, Xiao Wei Tan, Phern Chern TorSchizophrenia Research|September 18, 2023
A 12-month audit of clozapine associated myocarditis in a South Australian Local Health Network: The importance of screening and personalised titrationOlivia Carswell, Lisa R Wilton, Kerri Nicholls, et al.Schizophrenia Research|September 17, 2023
Time will tell: Associations between unbalanced time perspectives and symptom severity in individuals with schizophrenia spectrum disordersStefano Damiani, Cristina Zarbo, Maciej Stolarski, et al.Pageof 891